TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8933493

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (5 min of cycling at 75% VO2max)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quiet rest (30 min sitting quietly in a sound-dampened chamber)
Number of subjects: 0
Study: 1654592

Group type: EXPERIMENTAL
Intervention: Ispaghula husk
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 6130838

Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 28343553

Group type: EXPERIMENTAL
Intervention: Amitriptyline plus ALA (600 mg) and n-3 PUFAs (docosahexaenoic acid 250 mg and eicosapentaenoic acid 16.67 mg)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Amitriptyline plus ALA and n-3 PUFAs
Number of subjects: 84
Study: 27032639

Group type: EXPERIMENTAL
Intervention: Montelukast (add-on therapy)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard steroid treatment only (LDS group)
Number of subjects: 32
Study: 22628142

Group type: EXPERIMENTAL
Intervention: OROS methylphenidate
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 21411144

Group type: EXPERIMENTAL
Intervention: Face-to-face AED training programs
Number of subjects: 305

Group type: COMPARATOR
Intervention: Video-based AED training programs
Number of subjects: 305

Group type: COMPARATOR
Intervention: Face-to-face AED training programs emphasizing self-efficacy and perceived control
Number of subjects: 305

Group type: COMPARATOR
Intervention: Video-based AED training programs emphasizing self-efficacy and perceived control
Number of subjects: 305
Study: 19322661

Group type: EXPERIMENTAL
Intervention: Distress
Number of subjects: 146

Group type: COMPARATOR
Intervention: Fear of the future
Number of subjects: 146
Study: 17873192

Group type: EXPERIMENTAL
Intervention: Daily routine chest radiographs (CXRs)
Number of subjects: 559

Group type: COMPARATOR
Intervention: Clinically indicated CXRs
Number of subjects: 559

Group type: COMPARATOR
Intervention: Abandoning daily routine CXRs
Number of subjects: 559
Study: 15158627

Group type: EXPERIMENTAL
Intervention: WBRT and stereotactic radiosurgery
Number of subjects: 333

Group type: COMPARATOR
Intervention: WBRT alone
Number of subjects: 333
Study: 11701433

Group type: COMPARATOR
Intervention: Oral estrogen
Number of subjects: 8
Study: 9812772

Group type: EXPERIMENTAL
Intervention: Clonidine 150 micrograms
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Clonidine 75 micrograms
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sumatriptan 6 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Clonidine 75 micrograms + Sumatriptan 3 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study: 7702795

Group type: EXPERIMENTAL
Intervention: Intravenous E-3174 (20 mg infused over 4 h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous E-3174
Number of subjects: 0
Study: 3667138

Group type: EXPERIMENTAL
Intervention: Epidural anaesthesia
Number of subjects: 36

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 36
Study: 30005332

Group type: EXPERIMENTAL
Intervention: Self-regulation strategies following moderate intensity exercise
Number of subjects: 40

Group type: COMPARATOR
Intervention: 20 min moderate intensity exercise
Number of subjects: 40

Group type: COMPARATOR
Intervention: 20 min video (neutral condition)
Number of subjects: 40
Study: 30422443

Group type: EXPERIMENTAL
Intervention: Endobronchial photodynamic therapy based on fluorescent diagnostics of photosensibilizator accumulation.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard method of photodynamic therapy.
Number of subjects: 90
Study: 25499939

Group type: EXPERIMENTAL
Intervention: Xuezhikang 1200 mg daily
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Xuezhikang 2400 mg daily
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Xuezhikang
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 22479368

Group type: EXPERIMENTAL
Intervention: Financial incentive group (subsidized price of $55)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Control group (co-payment of $330-660)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Financial incentive group
Number of subjects: 258

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 258
Study: 20044689

Group type: EXPERIMENTAL
Intervention: Cemented Thompson hemiarthroplasty
Number of subjects: 400
Study: 18007158

Group type: EXPERIMENTAL
Intervention: iopamidol-370
Number of subjects: 166

Group type: COMPARATOR
Intervention: iodixanol-320
Number of subjects: 166
Study: 16121514

Group type: EXPERIMENTAL
Intervention: Hochuekkito
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 12358134

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (3 days per week of stationary bicycling for 45 min at 50-60% of heart rate reserve)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 35
Study: 10404442

Group type: EXPERIMENTAL
Intervention: Nurse home visiting programme supported by a social worker and paediatrician
Number of subjects: 181

Group type: COMPARATOR
Intervention: Standard community child health services
Number of subjects: 181
Study: 7488277

Group type: EXPERIMENTAL
Intervention: Low-dose cyclosporine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2317014

Group type: EXPERIMENTAL
Intervention: 4-AP (10 to 25 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (lactose capsules)
Number of subjects: 20
Study: 396053

Group type: COMPARATOR
Intervention: Praziquantel (1x20, 2x20, or 3x20 mg/kg)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Praziquantel (three oral doses of 20 mg/kg at 4-hour intervals)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Praziquantel (single oral dose of 50 mg/kg)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Praziquantel (treatment)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 31937342

Group type: EXPERIMENTAL
Intervention: Double-chamber syringe
Number of subjects: 146

Group type: COMPARATOR
Intervention: Classic syringes
Number of subjects: 146
Study: 31495374

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment or treatment without medications
Number of subjects: 0
Study: 28606657

Group type: EXPERIMENTAL
Intervention: FGF‐2 plus Gelfoam patch
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Gelfoam patch alone
Number of subjects: 138

Group type: COMPARATOR
Intervention: Observation alone
Number of subjects: 138
Study: 26061609

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (E2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sertraline (SERT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 0
Study: 23238653

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo supplement
Number of subjects: 103
Study: 21330451

Group type: EXPERIMENTAL
Intervention: Agility and perturbation training with standard exercise therapy
Number of subjects: 183

Group type: COMPARATOR
Intervention: Standard exercise program alone
Number of subjects: 183
Study: 19847724

Group type: EXPERIMENTAL
Intervention: Pre-treatment counselling
Number of subjects: 166

Group type: COMPARATOR
Intervention: No pre-treatment counselling (control group)
Number of subjects: 166
Study: 15961713

Group type: EXPERIMENTAL
Intervention: Levofloxacin (500 mg/100 mL/d for 3 days)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo (0.9% physiological serum)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 136

Group type: COMPARATOR
Intervention: Optimal care
Number of subjects: 136
Study: 12568978

Group type: EXPERIMENTAL
Intervention: Sulphide sensor system measuring sulcular sulphide levels (SU)
Number of subjects: 63
Study: 10616985

Group type: EXPERIMENTAL
Intervention: Endoscopic vein harvest (EVH)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Open vein harvesting (OVH)
Number of subjects: 100
Study: 8565025

Group type: EXPERIMENTAL
Intervention: Clindamycin hydrochloride 150 mg QID for 10 days
Number of subjects: 164

Group type: COMPARATOR
Intervention: Clindamycin hydrochloride 300 mg BID plus placebo BID for 10 days
Number of subjects: 164
Study: 1726893

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy for osteosarcoma (4 or 9 weeks) with high doses of methotrexate, vincristine, and citrovorum factor rescue or BCD (bleomycin, cytoxan, actinomycin D) and CDDP (cisplatin).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy continued for up to 2 years.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ewing's sarcoma treated with T-9 Rosen's regimen or Memphis group regimen.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiotherapy for primary tumor with doses adjusted to tumor response (30-50 Gy or 50 Gy).
Number of subjects: 0
Study: 7034472

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside infusion during 24 hours, followed by six times a day 5 mg isosorbide dinitrate for seven days
Number of subjects: 328

Group type: COMPARATOR
Intervention: Glucose 5% infusion
Number of subjects: 328
Study: 31816103

Group type: EXPERIMENTAL
Intervention: An Individualized Mental Health Intervention for Autism Spectrum Disorder (AIM HI)
Number of subjects: 46
Study: 30914334

Group type: EXPERIMENTAL
Intervention: Presence of basal cell hyperplasia (BCH) in baseline prostate biopsy
Number of subjects: 6471

Group type: EXPERIMENTAL
Intervention: BCH in baseline biopsy
Number of subjects: 6471
Study: 28708285

Group type: EXPERIMENTAL
Intervention: Green light (G-group)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Darkness (D-group)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Red light (R-group)
Number of subjects: 750
Study: 25240787

Group type: EXPERIMENTAL
Intervention: Perceived cognitive ability (PCA)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Perceived cognitive impairment (PCI)
Number of subjects: 88
Study: 23317527

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CPFX) 300 mg every 12h
Number of subjects: 51

Group type: COMPARATOR
Intervention: Cefepime (CFPM) 2g every 12h
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CPFX)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Cefepime (CFPM)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CPFX) and Cefepime (CFPM)
Number of subjects: 51
Study: 21277924

Group type: EXPERIMENTAL
Intervention: Kid's Choice Program (KCP)
Number of subjects: 382

Group type: COMPARATOR
Intervention: Control group (Good Citizenship Behaviors)
Number of subjects: 382
Study: 19297117

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT) intervention
Number of subjects: 94
Study: 17115380

Group type: EXPERIMENTAL
Intervention: Sumanirole 1 to 48 mg/day
Number of subjects: 948

Group type: EXPERIMENTAL
Intervention: Ropinirole 0.75 to 24 mg/day
Number of subjects: 948

Group type: COMPARATOR
Intervention: Sumanirole
Number of subjects: 948
Study: 16030435

Group type: EXPERIMENTAL
Intervention: 15 g alcohol per day for 8 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 30 g alcohol per day for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0 g alcohol (control group)
Number of subjects: 0
Study: 11908559

Group type: COMPARATOR
Intervention: Sedentary controls
Number of subjects: 93
Study: 11205831

Group type: EXPERIMENTAL
Intervention: Cold application
Number of subjects: 60
Study: 7535952

Group type: EXPERIMENTAL
Intervention: Concomitant chemoradiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mitomycin C, cisplatin, and 5‐fluorouracil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Accelerated hyperfractionation with or without chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reirradiation with concomitant chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concomitant, alternating or split course chemoradiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 1681960

Group type: EXPERIMENTAL
Intervention: Aspirin or non-aspirin NSAIDs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-secretory drugs and prostaglandins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short-term studies in humans
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 7008819

Group type: COMPARATOR
Intervention: 0.5% bupivacaine 3 ml with no glucose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine 3 ml with 5% glucose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine 3 ml with 8% glucose
Number of subjects: 0
Study: 31996053

Group type: EXPERIMENTAL
Intervention: Medicated chewing gum (MCG) with taste-masked LCZ (drug/Kleptose complex 1:3 molar ratio)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional tablets
Number of subjects: 0
Study: 30779597

Group type: EXPERIMENTAL
Intervention: Hourly resistance exercise breaks (REX)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Prolonged sitting (SIT)
Number of subjects: 14
Study: 28114769

Group type: EXPERIMENTAL
Intervention: Treatment as usual plus common factors feedback (TAU + CFF)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 79
Study: 23941811

Group type: EXPERIMENTAL
Intervention: Case-formulation driven CBT
Number of subjects: 54
Study: 25713916

Group type: EXPERIMENTAL
Intervention: Embryonal natural orifice transluminal endoscopic surgery (ENOTES)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery (laparotomy)
Number of subjects: 0
Study: 21612965

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided injection of steroid (betamethasone 7 mg)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard subacromial infiltration of 7 mg of betamethasone
Number of subjects: 70
Study: 19484679

Group type: EXPERIMENTAL
Intervention: Itraconazole (50 mg/day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (ambroxol hydrochloride 45 mg/day)
Number of subjects: 21
Study: 17327320

Group type: EXPERIMENTAL
Intervention: BFST-D
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Educational Support (ES)
Number of subjects: 104
Study: 15513279

Group type: EXPERIMENTAL
Intervention: 2.5 g creatine monohydrate in solution
Number of subjects: 6

Group type: COMPARATOR
Intervention: Creatine Serum (5 ml)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Water
Number of subjects: 6
Study: 11599461

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) administered in vivo
Number of subjects: 88

Group type: COMPARATOR
Intervention: No Growth Hormone (no GH)
Number of subjects: 88
Study: 9689343

Group type: EXPERIMENTAL
Intervention: Phadiatop
Number of subjects: 8329

Group type: EXPERIMENTAL
Intervention: Skin Prick Test (SPT)
Number of subjects: 8329

Group type: EXPERIMENTAL
Intervention: Total IgE
Number of subjects: 8329

Group type: COMPARATOR
Intervention: Skin Prick Test (SPT) vs Phadiatop
Number of subjects: 8329

Group type: COMPARATOR
Intervention: Skin Prick Test (SPT) vs Total IgE
Number of subjects: 8329
Study: 7991718

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid biogenic amines analysis in schizophrenia
Number of subjects: 36

Group type: COMPARATOR
Intervention: Neuroleptic treatment
Number of subjects: 36
Study: 2532790

Group type: EXPERIMENTAL
Intervention: Low-dose heparin (50 units/kg body weight intravenously immediately after antivenom followed by a continuous infusion of 10 units/kg/hr in isotonic saline for 24 hours)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Antivenom alone
Number of subjects: 28
Study: 29566539

Group type: EXPERIMENTAL
Intervention: Silicone oil tamponade in vitrectomized myopic eyes
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-vitrectomized highly myopic eyes
Number of subjects: 20
Study: 27919979

Group type: EXPERIMENTAL
Intervention: Erlotinib 150 mg/day (arm A)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Erlotinib 150 mg/day + Docetaxel 75 mg/m2 (arm B)
Number of subjects: 74
Study: 25265976

Group type: EXPERIMENTAL
Intervention: Group C (history of angina and chest pain)
Number of subjects: 4878

Group type: EXPERIMENTAL
Intervention: Group B (past history of angina)
Number of subjects: 4878

Group type: COMPARATOR
Intervention: Group A (no history of angina)
Number of subjects: 4878
Study: 22634443

Group type: EXPERIMENTAL
Intervention: Vaccine recipients
Number of subjects: 900

Group type: COMPARATOR
Intervention: Placebo recipients
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Participants in Africa
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Participants in Europe
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Participants in the US
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Participants in India
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: All regions
Number of subjects: 900
Study: 20406956

Group type: EXPERIMENTAL
Intervention: Regular home cooking
Number of subjects: 0
Study: 18029921

Group type: EXPERIMENTAL
Intervention: Fine-needle aspiration (FNA)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Fine-needle capillary (FNC) sampling
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Fine-needle aspiration (FNA) in solid nodules
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Fine-needle aspiration (FNA) in mixed cystic-solid nodules
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Fine-needle capillary (FNC) sampling in solid nodules
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Fine-needle capillary (FNC) sampling in mixed cystic-solid nodules
Number of subjects: 180
Study: 16105365

Group type: EXPERIMENTAL
Intervention: Educational package delivered by midwives and health visitors
Number of subjects: 1174

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1174
Study: 12450893

Group type: EXPERIMENTAL
Intervention: Plant sterols (NS)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Plant stanols (SS)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 50:50 mixture of sterols and stanols (NSS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Cornstarch (control)
Number of subjects: 15
Study: 10410615

Group type: EXPERIMENTAL
Intervention: Touched by waitress confederates
Number of subjects: 144

Group type: COMPARATOR
Intervention: Not touched by waitress confederates
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Touched by waitress confederates in mixed-gender dyads
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Same-gender (men-men) dyads
Number of subjects: 144
Study: 7670096

Group type: EXPERIMENTAL
Intervention: rhuGM‐CSF 5.0 micrograms/kg twice per day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: rhuGM‐CSF 10.0 micrograms/kg once per day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: rhuGM‐CSF 5.0 micrograms/kg once per day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2208436

Group type: EXPERIMENTAL
Intervention: Invigorating Spleen (IS) group treated by modified Yi‐Gong‐San for 3 months
Number of subjects: 101

Group type: COMPARATOR
Intervention: Replenishing zinc (RZ) group treated by 0.2% zinc sulphate syrup for 3 months
Number of subjects: 101
Study: 7429005

Group type: EXPERIMENTAL
Intervention: Erythromycin 2 x 1 g/day for 48 hours, infused over 30 or 60 minutes at 12-hour intervals
Number of subjects: 16
Study: 31006644

Group type: EXPERIMENTAL
Intervention: Kinematically aligned (KA) TKA
Number of subjects: 14

Group type: COMPARATOR
Intervention: Mechanically aligned (MA) TKA
Number of subjects: 14
Study: 30396383

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (group D)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol (group P)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Etomidate (group E)
Number of subjects: 60
Study: 27121539

Group type: EXPERIMENTAL
Intervention: 4-week extended-release naltrexone (XR-NTX)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Daily buprenorphine-naloxone (BP-NLX)
Number of subjects: 180
Study: 25225952

Group type: EXPERIMENTAL
Intervention: Two-day interactive education program
Number of subjects: 76

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 76
Study: 21718117

Group type: EXPERIMENTAL
Intervention: 100% human milk-based diet (mother's milk fortified with donor human milk-based HMF)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Bovine milk-based HMF-fortified diet
Number of subjects: 207
Study: 20953684

Group type: EXPERIMENTAL
Intervention: rosuvastatin 5 mg + fenofibric acid 135 mg
Number of subjects: 760

Group type: COMPARATOR
Intervention: rosuvastatin 5 mg
Number of subjects: 760

Group type: COMPARATOR
Intervention: fenofibric acid 135 mg
Number of subjects: 760
Study: 18030944

Group type: EXPERIMENTAL
Intervention: Website intervention for chronic low back pain management
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (15 patients)
Number of subjects: 20
Study: 16102948

Group type: EXPERIMENTAL
Intervention: Epoetin alfa 150 IU/kg three-times-a-week (t.i.w.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Epoetin alfa 40,000 IU weekly (q.w.)
Number of subjects: 0
Study: 12110340

Group type: EXPERIMENTAL
Intervention: Intralesional vinblastine (VNB)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 3% sodium tetradecyl sulfate (STS)
Number of subjects: 16
Study: 10773184

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8737889

Group type: EXPERIMENTAL
Intervention: Ceruletide (CRL) 0.5 micrograms
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Ceruletide (CRL) 5 micrograms
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 1482222

Group type: EXPERIMENTAL
Intervention: Transdermal clonidine treatment (Catapres‐TTS No. 2)
Number of subjects: 375

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 375
Study: 3904334

Group type: EXPERIMENTAL
Intervention: Low energy diet supplemented with sodium chloride (Group I)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Energy-reduced diet with sodium restriction (Group II)
Number of subjects: 30